Univariate and multivariate analyses for predictors of resolution and improvement of cranial neuropathy
| Variable | Univariate | Multivariate | ||||
| Improved | Unimproved | P value | OR | 95% CI | P value | |
| No. of patients | 51 | 15 | ||||
| Age (years) | 69 (57–75) | 66 (55–75) | 0.613 | |||
| Women | 46 (90) | 11 (73) | 0.192 | |||
| Hypertension | 30 (59) | 7 (47) | 0.555 | |||
| Dyslipidemia | 19 (37) | 6 (40) | 1.000 | |||
| Diabetes mellitus | 1 (2) | 3 (20) | 0.034 | 25.8 | 0.06 to 11 739.28 | 0.298 |
| Smoker | 17 (33) | 4 (27) | 0.758 | |||
| Aneurysm size ≥20 mm | 21 (41) | 7 (47) | 0.771 | |||
| Aneurysm neck ≥8 mm | 28 (55) | 6 (40) | 0.384 | |||
| Complete paresis | 4 (11) | 2 (33) | 0.182 | |||
| Onset-to-treatment <6 months | 36 (71) | 3 (21) | 0.002 | 24.2 | 3.09 to 188.84 | 0.002 |
| Steroid use | 16 (31) | 3 (20) | 0.524 | |||
| Adjunctive coiling | 9 (18) | 9 (60) | 0.003 | 5.9 | 0.77 to 45.08 | 0.087 |
| Aneurysm occlusion* | ||||||
| 6 Months | 40 (78) | 9 (60) | 0.185 | |||
| 12 Months | 45 (88) | 11 (73) | 0.217 | |||
| Shrinkage of aneurysm | 32 (63) | 1 (7) | 0.0002 | 23.1 | 1.97 to 271.75 | 0.012 |
Values shown are medians (IQR) or numbers (%).
*Aneurysm occlusion is defined as O’Kelly–Marotta grade C or D.